Drilldown: Medicines
Appearance
Medicines > fda max
:
2550 mg/d (IR); 2000 mg/d (ER)
or
Indication-specific
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
:
2550 mg/d (IR); 2000 mg/d (ER)
or
Indication-specific
& onset:
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
There are no results for this report.

